TrialEuropean journal of nuclear medicine and molecular imaging2025

HER2-targeted PET/CT imaging provides potential biomarkers for differentiating HER2-zero, -low, and -positive breast cancer.

Yuan Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.